The company held its 2026 annual meeting of stockholders on June 12, 2026. Keith A. Goldan and Bernhardt G. Zeiher, M.D. were elected as Class 1 directors until 2029. Stockholders approved the advisory vote on executive compensation. Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026. Shareholders approved an increase in shares reserved for the 2023 Equity Incentive Plan from 8.4 million to 11.5 million. A proposal to remove the advance notice provision for director nominations failed to reach the required 66 2/3% supermajority vote.